John Oliver examines Trump administration scandal and generic drug industry issues
The segment covers a scandal involving Kimberly Guilfoyle's credit card expenses within the Trump administration, followed by an investigation into the generic drug industry, including why generic medications can differ from brand-name counterparts and what those differences mean for patients.
Why we included this story▾▴
Learn about our confidence system → · What qualifies a story →
Stay with this story
Response links are not endorsements. They are restrained ways to learn more, track updates, and ask better questions.
Share responsibly
Share the story with context, not outrage. Include what is known and what remains unclear.
Eligibility: Contested political stories are limited to learning, tracking, and careful sharing. View taxonomy →
Did this feel useful, agenda-driven, or unclear?
Get stories like this every morning.
Free daily briefing, 5 minutes, no spin.
Free. No spam. Unsubscribe anytime.